The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Saved in:
| Title: | The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. |
|---|---|
| Authors: | Malempati S; Department of Pediatrics, Oregon Health & Science University, Portland, Oregon., Weigel BJ; Division of Pediatric Hematology/Oncology and Blood and Marrow Transplant, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota., Chi YY; Department of Biostatistics, University of Florida, Gainesville, Florida., Tian J; Department of Biostatistics, University of Florida, Gainesville, Florida., Anderson JR; Merck and Co, North Wales, Pennsylvania., Parham DM; Department of Pediatrics, Children's Hospital of Los Angeles and University of Southern California Keck School of Medicine, Los Angeles, California., Teot LA; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Rodeberg DA; Department of Surgery, East Carolina University, Greenville, North Carolina., Yock TI; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Shulkin BL; Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Spunt SL; Stanford University School of Medicine, Stanford, California., Meyer WH; Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Hawkins DS; Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington. |
| Source: | Cancer [Cancer] 2019 Jan 15; Vol. 125 (2), pp. 290-297. Date of Electronic Publication: 2018 Oct 23. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
